• Ribociclib, Acid Reduction, and pH-Mediated Interaction

  2026-09-22

  This study applies an Analytical Quality by Design framework and biorelevant micro-dissolution testing to assess whether gastric pH elevation could alter ribociclib succinate solubility. The observed reductions after gastric and intestinal pH shifts were not interpreted as clinically meaningful, while the workflow offers a practical early-stage approach for evaluating pH-mediated interactions.

• Berbamine Hydrochloride: NF-κB Meets Ferroptosis

  2026-09-22

  A translational framework for evaluating Berbamine hydrochloride as a mechanistic probe at the intersection of NF-κB signaling, STAT3 activity, calcium homeostasis, and ferroptosis resistance in leukemia and hepatocellular carcinoma models.

• SNORA38B in NSCLC Immunotherapy Resistance

  2026-09-21

  This study identifies the snoRNA SNORA38B as an oncogenic regulator in non-small cell lung cancer (NSCLC) that links E2F1-dependent GAB2 transcription with AKT/mTOR signaling and an immunosuppressive tumor microenvironment. Its inhibition with locked nucleic acids reduced tumor-promoting activity and improved responsiveness to immune checkpoint blockade in a mouse model, supporting SNORA38B as a candidate biomarker and therapeutic target.

• Sphingolipid Inhibition, HIF-1, and Ferroptosis

  2026-09-21

  The reference study shows that myriocin protects HT22 neuronal cells from erastin- or glutamate-induced ferroptosis by activating HIF-1 rather than simply restoring glutathione. Its key mechanistic advance is linking sphingolipid synthesis to HIF1α stability through reduced ubiquitination and proteasomal degradation, providing a framework for studying ferroptosis control in neurological disease models.

• NSP15 Inhibitor Screening: Thymopentin and Oleuropein

  2026-09-20

  This 2021 study used structure-based virtual screening and molecular dynamics simulations to identify thymopentin and oleuropein as computationally promising binders of SARS-CoV-2 NSP15. Its main contribution is a prioritized framework for targeting a viral immune-evasion enzyme, while the findings remain preliminary until confirmed with biochemical, cellular, and infection-model experiments.

• SARS-CoV-2 NSP15 Screening: Two Natural-Product Leads

  2026-09-19

  The reference study used structure-based virtual screening and molecular dynamics simulations to prioritize natural products targeting the SARS-CoV-2 NSP15 endoribonuclease. Thymopentin and oleuropein showed the strongest computational profiles, but biochemical, cellular, and clinical studies are still required to determine whether these candidates inhibit viral infection.

• Genistein for Mechanostress and Autophagy Assays

  2026-09-19

  Use Genistein to separate growth-factor kinase signaling, cytoskeletal mechanotransduction, autophagy, and cytotoxicity in a controlled cell-based workflow. This guide combines compression-stress assay design with practical dose selection, orthogonal readouts, and cancer-biology applications.

• Doxycycline: MMP-Informed Research Workflows

  2026-09-18

  Learn how to deploy Doxycycline in reproducible cancer, metalloproteinase, and antimicrobial assays while avoiding solubility and mechanism-related confounders. This guide also translates an MMP-2-responsive peptide delivery study into practical assay controls without confusing Doxycycline with doxorubicin.

• Shaped ABC Coil-Bottlebrush Terpolymer Self-Assembly

  2026-09-17

  The reference study examines how digitally shaped bottlebrush segments influence phase behavior in ABC coil–bottlebrush triblock terpolymers. Across a library of narrowly distributed polymers, SAXS showed robust segregation but predominantly hexagonal and lamellar morphologies, while the double-gyroid phase was systematically suppressed and ordering remained unexpectedly slow.

• Praeruptorin A: Mechanism-to-Assay Roadmap

  2026-09-17

  Praeruptorin A is an angular pyranocoumarin compound with interconnected effects on ferroptosis, inflammation, barrier integrity, metastasis, and myocardial injury. This mechanism-to-assay roadmap explains how to test those effects without confusing pathway association with causality.

• QX77 Molecular Chaperone Activator Workflows

  2026-09-16

  QX77 supports targeted investigation of LAMP2A- and Rab11-linked autophagy processes while offering a practical bridge to stem cell differentiation assays. This guide provides an assay-ready workflow, reference-study context, and troubleshooting strategies without overstating its preclinical scope.

• SB525334: Precision Across the TGF-β1 Axis

  2026-09-16

  TGF-β1 can drive pathological fibrosis yet support vascularized tissue repair. This thought-leadership article examines how SB525334 enables precise ALK5 pathway interrogation, connects renal and wound-healing models, and helps translational researchers distinguish therapeutic inhibition from context-dependent pathway biology.

• Machine Learning for Senolytic Discovery

  2026-09-15

  The 2023 Nature Communications study developed machine-learning models from published senolytic data and used them to identify ginkgetin, periplocin, and oleandrin as active compounds. Its main contribution is methodological: carefully curated, heterogeneous literature data can support substantially lower-cost early drug discovery when computational predictions are paired with cell-based validation.

• Ceramides Enable RGNNV Replication via Autophagy

  2026-09-15

  A lipidomics study shows that red-spotted grouper nervous necrosis virus reshapes host sphingolipid metabolism, with ceramide accumulation supporting viral replication. Pharmacological inhibition, knockdown, rescue with C16-ceramide, and autophagy experiments identify ceramide flux as a mechanistically actionable host factor while also defining important limits for translation.

• Nebivolol hydrochloride: Assay Workflows

  2026-09-14

  Nebivolol hydrochloride enables selective β1-receptor pathway interrogation while also serving as a useful negative comparator in drug-sensitized yeast mTOR screens. This guide covers solvent handling, concentration-response design, cross-platform controls, and troubleshooting for cardiovascular pharmacology research.

8037 records 1/536 page Next 12345 下5页 Last page